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To the Editors,

There is a clear link between schizophrenia and exposure to childhood maltreatment (CM)  ADDIN EN.CITE (Varese et al., 2012). Hyperactivity within the hypothalamic-pituitary-adrenal (HPA) stress response pathway has been proposed to mediate this (Walker et al., 2008). CM leads to HPA hyper-reactivity via methylation of the glucocorticoid receptor (NR3C1) gene, which represses NR3C1 transcription  ADDIN EN.CITE (Labonte et al., 2012; McGowan et al., 2009; Radtke et al., 2015). Hippocampal expression of BDNF is suppressed secondary to stress-induced down-regulation of the NR3C1 receptor  ADDIN EN.CITE (Murakami et al., 2005). Epigenetic changes in BDNF have been suggested as being involved both in schizophrenia development and in mediating the effects of CM  ADDIN EN.CITE (Ikegame et al., 2013; Kordi-Tamandani et al., 2012). Oxytocin also plays a key role in the stress response pathway and BDNF up-regulates oxytocin secretion (Moreno et al., 2011). We explored the potential impact of CM on methylation status at the NR3C1, BDNF and OXTR genes in those with schizophrenia in order to elucidate the potential mechanism by which environmental exposures could confer susceptibility to these disorders. 

Ninety-four adults aged 18–65 meeting DSM-IV criteria for schizophrenia or schizoaffective disorder were recruited from outpatient populations in South East Scotland. Current alcohol or drug dependency, neurological illness, or past head injury were exclusion criteria. Ethical approval was obtained from the National Research Ethics Service and NHS (Research and Development) and all participants signed to declare they gave informed consent. Childhood Trauma Questionnaire (CTQ) was used to assess CM. 

DNA was extracted from blood samples and DNA methylation profiled using the Infinium HumanMethylation450 BeadChip (Illumina Inc., San Diego, California). Outlier and poor-performing samples and sites were excluded. Data normalisation was performed and data were converted to M-values. Surrogate variable analysis was carried out. Differentially methylated positions (DMPs) were identified by linear modelling using the R package limma (Ritchie et al., 2015). The relationship between DNA methylation and CM was assessed by considering: (i) total CTQ score; and (ii) scores on each of the five CTQ subscales separately examined as log-transformed continuous variables. M-values were fitted as the outcome variable and age, sex, Pre-morbid IQ (National Adult Reading Test score), social class at birth, Brief Life Events Questionnaire score and significant surrogate variables were included as covariates. 

Seventy-three sites were examined within the BDNF gene, 25 within the NR3C1 gene and 14 within the OXTR gene, including their promoter regions. Correction for multiple testing was performed using the Benjamin-Hochberg false discovery rate (FDR). 

The study group comprised 63 males and 31 females, mean age 45.8 years (SD 11), mean NART score of IQ 112 (SD 8). CTQ scores ranged from 25-100. In the analysis of CTQ scores as a continuous variable, methylation at a site in the NR3C1 promoter region was significantly increased in association with childhood sexual abuse (CSA) (cg08845721, FDR corrected p=0.035). There was a significant association between increased methylation at a site in BDNF and emotional neglect (CEN) (cg18595174, FDR corrected p= 0.09) (see table 1). There was no significant association found between methylation at the oxytocin receptor gene and CM.  A persistent problem in the study of psychiatric disorders is the difficulty in studying the most physiologically relevant tissue (i.e. the brain). It is established that there is a strong intra-individual correlation between peripheral and brain tissue, including hippocampal tissue, for BDNF methylation  ADDIN EN.CITE (Stenz et al., 2015). Examination of the Hannon online database (http://epigenetics.iop.kcl.ac.uk/bloodbrain/)(Hannon et al., 2015) demonstrated that the NR3C1 locus (cg08845721) showed a significant correlation between methylation in the blood and in the entorhinal cortex, closely related to the hippocampus(see table 1). 

We identified methylation differences at loci in the NR3C1 and BDNF genes that were significantly associated with CSA and CEN respectively as measured by the CTQ. This was a small study but the findings are interesting because they show that these environmental exposures which are known to increase risk of schizophrenia alter methylation at genes involved in the HPA axis which is a process that has also been linked to schizophrenia  Our findings are also consistent with those of previous studies of DNA methylation in other psychiatric disorders  ADDIN EN.CITE (Perroud et al., 2013; Weder et al., 2014). This provides rationale for future studies looking at the methylation of these loci associated with CM and schizophrenia.  While methylation of the site within NR3C1 was significantly associated with CSA, methylation of the site within BDNF gene was associated with CEN. It may be that different types of CM exert effects on different genes within the HPA pathway preferentially. However, this may also be the result of there being a small sample size. 

This study has certain limitations including a small sample size and thus replication in a larger, independent sample is needed. While the analysis adjusted for several important confounders use of psychotropic medication was not fitted. However, use of anti-psychotic medication was almost ubiquitous in our sample (97.2%).  We did not include a control group with or without a history of CM. A review of the medical records was not performed but a number of studies have shown good reliability and validity of assessments of CM in patients with schizophrenia (Darves-Bornoz et al., 1995).
 
Our findings raise interesting questions about how CM may influence neurobiological changes, for example in hippocampal volume, via pathways such as the HPA axis in schizophrenia and schizoaffective disorder and specifically about the involvement of altered methylation of key genes in this pathway like the glucocorticoid receptor (NR3C1) and BDNF.  Changes in methylation in NR3C1 and BDNF secondary to CM have been found to be reversed by behavioural, chemical and psychotherapeutic intervention (Perroud et al., 2013). With this emerges the prospect that the influence of CM in modulating the risk and expression of schizophrenia is amenable to treatment. 
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